IP, protection, IP protection, India, CDMO, IPR, intellectual property,

India on the radar for CDMO services

Prof. Dr. Rolf G. Werner, Professorship for Industrial Biotechnology, Eberhard Karls University of Tuebingen, Germany gave an in-depth presentation at last year’s BioPharma India Convention 2014 on CDMO services in India. In his presentation, Dr Werner covered: Intellectual property in India (pharma products) Current IPR regime in India Current India data protection regime Internal measures at CDMO Download presentation As IP …

Download: Understanding and overcoming intellectual property and patent law concerns when developing antibody therapeutics

Download this presentation here > The European Antibody Congress  brings together big pharma, big biotech, SME Biotech, academia, regulators and the wider service provider community to discuss the latest R&D and advances in the antibody space – across mAbs, ADCs, bispecifics, multispecifics, and protein scaffolds. At the 2013 event, delegates were fortunate enough to hear from Dr Antonio Maschio, Partner, Maschio and Soames LLP,  who …

Brinks: Avoiding ownership disputes in intellectual property collaborations

In the drive to identify new therapeutic technologies, the pharma industry is increasingly looking to form strategic collaborations with other members of the industry in order to mix creative ideas and technical insight. For a successful outcome, it is important that both parties have a clear understanding of what each party is to gain from the collaboration. Identifying ownership of …